{"id":"W2921242005","doi":"10.1200/jco.2019.37.7_suppl.568","title":"Efficacy of targeted therapy (TT) after checkpoint inhibitors (CPI) in metastatic renal cell carcinoma (mRCC): Results from the Canadian Kidney Cancer Information System (CKCis).","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Western University; Ottawa Hospital; University of British Columbia; London Health Sciences Centre; McMaster University; Juravinski Cancer Centre; Dalhousie University; Hôtel-Dieu de Québec; Centre Hospitalier de l’Université de Montréal; University of Calgary; University of Alberta","funders":"","keywords":"Medicine; Nivolumab; Axitinib; Renal cell carcinoma; Hazard ratio; Internal medicine; Cancer; Kidney cancer; Ipilimumab; Oncology; Urology; Gastroenterology; Sunitinib; Immunotherapy; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002579973,0.0002887545,0.0004367526,0.0007737612,0.0002876749,0.0005669519,0.0003744231,0.0002733443,0.0009024462],"category_scores_gemma":[0.003162402,0.00008697416,0.0007571418,0.001642297,0.0002174901,0.0002469777,0.0002932833,0.0004898564,0.0001228027],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.004080934,"about_ca_system_score_gemma":0.002748272,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.1641261,"about_ca_topic_score_gemma":0.2434417,"domain_scores_codex":[0.9988077,0.0002217469,0.0000907451,0.0001515983,0.0005724655,0.0001557452],"domain_scores_gemma":[0.9962121,0.0009713503,0.00145903,0.0001485204,0.0007518279,0.0004571655],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01101857,0.0002309211,0.9350867,0.0006435526,0.00111801,0.00006414277,0.00009906498,0.001610744,0.0006107895,0.00007379724,0.003686528,0.04575719],"study_design_scores_gemma":[0.0002525621,0.001372764,0.9951406,0.00004668993,0.0004054962,0.00006326679,0.00003409058,0.0005146471,0.0002717501,0.00001756979,0.001869599,0.00001102251],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9667012,0.01016989,0.0002707552,0.0003928497,0.00002396306,0.0001347641,0.01965492,0.00002940606,0.002622314],"genre_scores_gemma":[0.9903853,0.001106897,0.0001181442,0.00007848837,0.00002184057,0.00002128133,0.008041859,0.000004092051,0.0002220367],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1641261,"threshold_uncertainty_score":0.3263416,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05934665579512874,"score_gpt":0.3556969391781236,"score_spread":0.2963502833829949,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}